Cargando…
The Molecular Biology of Prostate Cancer Stem Cells: From the Past to the Future
Prostate cancer (PCa) continues to rank as the second leading cause of cancer-related mortality in western countries, despite the golden treatment using androgen deprivation therapy (ADT) or anti-androgen therapy. With decades of research, scientists have gradually realized that the existence of pro...
Autores principales: | Zhou, Yong, Li, Tian, Jia, Man, Dai, Rongyang, Wang, Ronghao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140972/ https://www.ncbi.nlm.nih.gov/pubmed/37108647 http://dx.doi.org/10.3390/ijms24087482 |
Ejemplares similares
-
The Role of Androgen Receptor in Cross Talk Between Stromal Cells and Prostate Cancer Epithelial Cells
por: Tang, Qianyao, et al.
Publicado: (2021) -
Vascular mimicry induced by m(6)A mediated IGFL2-AS1/AR axis contributes to pazopanib resistance in clear cell renal cell carcinoma
por: Cheng, Bo, et al.
Publicado: (2023) -
Past, Current, and Future of Immunotherapies for Prostate Cancer
por: Boettcher, Adeline N., et al.
Publicado: (2019) -
Pioneer of prostate cancer: past, present and the future of FOXA1
por: Teng, Mona, et al.
Publicado: (2020) -
Particle therapy for prostate cancer: The past, present and future
por: Ishikawa, Hitoshi, et al.
Publicado: (2019)